I will start by acknowledging, as several have, Mr. Keon in particular, that the drug industry is global. Whether we're referring to generic or patented drugs, it is a global industry with inputs from around the world. There are multiple ways in which the supply, the supply chain, the flow of drugs can be affected. That's a starting point.
The drug companies—all of them—are required by law, and they do follow this, to report any drug shortages on a Government of Canada website, drugshortagescanada.ca. We have been monitoring that website on a daily basis, just to see where the shortages might be. I'm not quite sure how to respond to a charge of lack of transparency, because this is followed through.
As I said earlier, with our companies we have been extremely vigilant in monitoring any drug shortages, not only from the website itself, but also through talking with our companies on a regular basis, sometimes daily. While we recognize the need to continue to be vigilant, we have not found ourselves in a position where we've been unable to supply the drugs that have been needed.
That being said, I think there's a slightly different story on the generic side. You may wish to also throw your question over to Mr. Keon.